Kite Reports Second Quarter 2017 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/24/2026

1. DECK
2. RNG
3. WDC
4. BYD
5. WCN
6. SPOT
7. BMY
8. SPY
9. FIX
10. TSCO

Go back to Kite Reports Second Quarter 2017 Financial Results

Kite Pharma (KITE) PT Raised to $120 at Canaccord Genuity

August 8, 2017 12:51 PM EDT

Canaccord Genuity raised its price target on Kite Pharma (NASDAQ: KITE) to $120.00 (from $115.00) while maintaining a Buy rating.

Analyst John Newman with the coverage.

... More

Kite Pharma (KITE) Post Smaller Q2 Loss on Higher Revs

August 8, 2017 8:01 AM EDT

Kite Pharma (NASDAQ: KITE) reported Q2 EPS of ($1.50), $0.48 better than the analyst estimate of ($1.98). Revenue for the quarter came in at $10.1 million versus the consensus estimate of $9.59 million.

"We've continued to make significant progress on key clinical and commercial milestones in the... More